Updated Date:
17 Apr 2026
Product Detail:
INCRELEX mecasermin 10 mg/mL solution for injection vial
Shortage Status:
Anticipated
AUST R:
308494
Availability:
Available
Active Ingredient:
Mecasermin
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Injection,solution
Supply Impact Dates
From 01 May 2026
To 25 Feb 2027
Management Action:
An overseas-registered product has been approved for supply under Section 19A. The approval holder, Asteri Pharma Pty Ltd, can be contacted for details on supply on 1800 175 659.